Trinity Biotech Acquires Prostate Cancer Test Developer EpiCapture

Ticker: TRIB · Form: 6-K · Filed: Oct 25, 2024 · CIK: 888721

Trinity Biotech PLC 6-K Filing Summary
FieldDetail
CompanyTrinity Biotech PLC (TRIB)
Form Type6-K
Filed DateOct 25, 2024
Risk Levelmedium
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: acquisition, diagnostics, healthcare

TL;DR

Trinity Biotech just bought EpiCapture, a prostate cancer test company. Big move for diagnostics.

AI Summary

On October 25, 2024, Trinity Biotech PLC announced its acquisition of EpiCapture Limited, a company focused on developing a non-invasive test for monitoring aggressive prostate cancer risk. This acquisition is being incorporated by reference into Trinity Biotech's existing S-8 and F-3 registration statements.

Why It Matters

This acquisition expands Trinity Biotech's portfolio in the diagnostics sector, potentially offering a new non-invasive tool for prostate cancer monitoring.

Risk Assessment

Risk Level: medium — Acquisitions carry inherent risks related to integration, market reception, and the actual performance of the acquired entity.

Key Players & Entities

  • Trinity Biotech PLC (company) — Acquiring company
  • EpiCapture Limited (company) — Acquired company
  • October 25, 2024 (date) — Date of announcement

FAQ

What is the primary focus of the acquired company, EpiCapture Limited?

EpiCapture Limited is developing a non-invasive test for monitoring the risk of aggressive prostate cancer.

What type of SEC filing is this document?

This document is a Form 6-K, a Report of Foreign Private Issuer.

What is the significance of the Form 6-K being incorporated by reference into other registration statements?

It means the information in this 6-K is now part of Trinity Biotech's S-8 and F-3 registration statements, which are used for registering securities offerings.

What is Trinity Biotech PLC's principal executive office located?

Trinity Biotech PLC's principal executive office is located in IDA Business Park, Bray, County Wicklow, Ireland.

What is the SIC code for Trinity Biotech PLC?

The Standard Industrial Classification (SIC) code for Trinity Biotech PLC is 2835, for In Vitro & In Vivo Diagnostic Substances.

Filing Stats: 222 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-10-25 13:23:08

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: October 25, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.